These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744 [TBL] [Abstract][Full Text] [Related]
3. CHA Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. Olesen JB; Fauchier L; Lane DA; Taillandier S; Lip GYH Chest; 2012 Jan; 141(1):147-153. PubMed ID: 21680645 [TBL] [Abstract][Full Text] [Related]
5. Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA2DS2-VASc Score of 1 (Men) or 2 (Women)? Hung Y; Chao TF; Liu CJ; Tuan TC; Lin YJ; Chang SL; Lo LW; Hu YF; Liao JN; Chung FP; Lin WY; Lin WS; Cheng SM; Chen TJ; Lip GY; Chen SA J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27702803 [TBL] [Abstract][Full Text] [Related]
6. Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study. Chao TF; Lip GY; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA Stroke; 2016 Oct; 47(10):2462-9. PubMed ID: 27625386 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the CHA Yao X; Gersh BJ; Sangaralingham LR; Kent DM; Shah ND; Abraham NS; Noseworthy PA Am J Cardiol; 2017 Nov; 120(9):1549-1556. PubMed ID: 28844514 [TBL] [Abstract][Full Text] [Related]
8. CHA Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228 [TBL] [Abstract][Full Text] [Related]
9. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809 [TBL] [Abstract][Full Text] [Related]
10. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin. Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB; J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of stroke and the need for thromboprophylaxis in young patients with atrial fibrillation: a cohort study. Lin AH; Oakley LS; Phan HL; Shutt BJ; Birgersdotter-Green U; Francisco GM J Cardiovasc Med (Hagerstown); 2014 Mar; 15(3):189-93. PubMed ID: 24625564 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of a nongovernmental organization-led large-scale community atrial fibrillation screening program using the smartphone electrocardiogram: An observational cohort study. Chan NY; Choy CC; Chan CK; Siu CW Heart Rhythm; 2018 Sep; 15(9):1306-1311. PubMed ID: 29890321 [TBL] [Abstract][Full Text] [Related]
13. A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme. Proietti M; Mairesse GH; Goethals P; Scavee C; Vijgen J; Blankoff I; Vandekerckhove Y; Lip GY; Europace; 2016 Dec; 18(12):1779-1786. PubMed ID: 27170000 [TBL] [Abstract][Full Text] [Related]
14. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation. Saliba W; Rennert G Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101 [TBL] [Abstract][Full Text] [Related]
15. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study. Potpara TS; Polovina MM; Marinkovic JM; Lip GY Int J Cardiol; 2013 Oct; 168(5):4744-9. PubMed ID: 23958417 [TBL] [Abstract][Full Text] [Related]
16. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project. Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935 [TBL] [Abstract][Full Text] [Related]
17. [Atrial fibrillation and stroke]. Aamodt AH; Sandset PM; Atar D; Tveit A; Russell D Tidsskr Nor Laegeforen; 2013 Aug; 133(14):1453-7. PubMed ID: 23929293 [TBL] [Abstract][Full Text] [Related]
18. The predictive ability of the CHADS2 and CHA2DS2-VASc scores for bleeding risk in atrial fibrillation: the MAQI(2) experience. Barnes GD; Gu X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Besley D; Krol GD; Froehlich JB; Kaatz S Thromb Res; 2014 Aug; 134(2):294-9. PubMed ID: 24929840 [TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation. Zhu WG; Xiong QM; Hong K Tex Heart Inst J; 2015 Feb; 42(1):6-15. PubMed ID: 25873792 [TBL] [Abstract][Full Text] [Related]
20. CHA Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]